Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinomaTAAL, Babs G; PETERSE, Hans; BOOT, Henk et al.Cancer. 2000, Vol 89, Num 11, pp 2214-2221, issn 0008-543XArticle

Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic functionSIEGEL-LAKHAI, Wandena S; CRUL, Mirjam; DE PORRE, Peter et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4558-4564, issn 0732-183X, 7 p.Article

Optimal locoregional treatment in gastric cancerJANSEN, Edwin P. M; BOOT, Henk; VERHEIJ, Marcel et al.Journal of clinical oncology. 2005, Vol 23, Num 20, pp 4509-4517, issn 0732-183X, 9 p.Article

Randomized trial of Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancerVERWAAL, Vic J; VAN RUTH, Serge; DE BREE, Eelco et al.Journal of clinical oncology. 2003, Vol 21, Num 20, pp 3737-3743, issn 0732-183X, 7 p.Article

Dissemination patterns in non-gastric MALT lymphomaDE BOER, Jan Paul; FREDERIK HIDDINK, Reinier; RADERER, Markus et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 201-206, issn 0390-6078, 6 p.Article

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori EradicationHONGXIANG LIU; HONGTAO YE; MOLINA, Thierry et al.Gastroenterology (New York, NY. 1943). 2002, Vol 122, Num 5, pp 1286-1294, issn 0016-5085Article

The role of parallel stent insertion in patients with esophagorespiratory fistulasVAN DEN BONGARD, H. J. G. Desirée; BOOT, Henk; BAAS, Paul et al.Gastrointestinal endoscopy. 2002, Vol 55, Num 1, pp 110-115, issn 0016-5107Article

Phase i pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/ fluorouracil/leucovorin (FOLFOX4) in patients with solid tumorsSIEGEL-LAKHAI, Wandena S; BEIJNEN, Jos H; SCHELLENS, Jan H. M et al.Clinical cancer research. 2007, Vol 13, Num 15, pp 4495-4502, issn 1078-0432, 8 p., 1Article

Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphomaDE JONG, Daphne; VYTH-DREESE, Florry; DELLEMIJN, Trees et al.Journal of pathology. 2001, Vol 193, Num 3, pp 318-324, issn 0022-3417Article

Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trialVAN HEEL, Nicole C. M; HARINGSMA, Jelle; BOOT, Henk et al.Gastrointestinal endoscopy (Print). 2012, Vol 76, Num 1, pp 52-58, issn 0016-5107, 7 p.Article

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometryHELGASON, Helgi H; ENGWEGEN, Judith Y. M. N; ZAPATKA, Marc et al.Oncology reports. 2010, Vol 24, Num 1, pp 57-64, issn 1021-335X, 8 p.Article

Dose-finding phase i clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumorsKUPPENS, Isa E. L. M; DANSIN, Eric; BOOT, Henk et al.Clinical cancer research. 2006, Vol 12, Num 12, pp 3774-3781, issn 1078-0432, 8 p.Article

Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric CancerDIKKEN, Johan L; JANSEN, Edwin P. M; VERHEIJ, Marcel et al.Journal of clinical oncology. 2010, Vol 28, Num 14, pp 2430-2436, issn 0732-183X, 7 p.Article

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trialHORNS, Marjolein Y. V; STEYERBERG, Ewout W; BOOT, Henk et al.Lancet (British edition). 2004, Vol 364, Num 9444, pp 1497-1504, issn 0140-6736, 8 p.Article